Abeona Therapeutics Inc.
ABEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $228,637 | $107,114 | $24,215 | $33,473 |
| - Cash | $23,357 | $14,473 | $14,217 | $32,938 |
| + Debt | $23,048 | $5,400 | $7,627 | $9,378 |
| Enterprise Value | $228,328 | $98,041 | $17,625 | $9,913 |
| Revenue | $0 | $3,500 | $1,414 | $3,000 |
| % Growth | -100% | 147.5% | -52.9% | – |
| Gross Profit | -$2,907 | $1,895 | $964 | $3,000 |
| % Margin | – | 54.1% | 68.2% | 100% |
| EBITDA | -$56,619 | -$50,572 | -$34,383 | -$76,816 |
| % Margin | – | -1,444.9% | -2,431.6% | -2,560.5% |
| Net Income | -$63,734 | -$54,188 | -$39,696 | -$84,936 |
| % Margin | – | -1,548.2% | -2,807.4% | -2,831.2% |
| EPS Diluted | -1.55 | -2.53 | -5.53 | -21.5 |
| % Growth | 38.7% | 54.2% | 74.3% | – |
| Operating Cash Flow | -$56,015 | -$37,009 | -$43,483 | -$65,665 |
| Capital Expenditures | -$2,446 | -$331 | -$130 | -$4,151 |
| Free Cash Flow | -$58,461 | -$37,340 | -$43,613 | -$69,816 |